ABBV vs ETN: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Eaton Corporation plc — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-08-06.
AbbVie Inc. · Healthcare
$261.07
+1.2% upside to fair value
Grade C
High Quality
VS
Eaton Corporation plc · Industrials
$447.28
-9.5% upside to fair value
Med Conviction
Grade C+
QuantHub Verdict
ABBV has more upside to fair value
(+1.2%).
ETN trades at a lower forward P/E
(33.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
ETN |
| Current Price |
$261.07 |
$447.28 |
| Fair Value Estimate |
$264.30 |
$405.00 |
| Upside to Fair Value |
+1.2%
|
-9.5%
|
| Market Cap |
$461.3B |
$173.7B |
| Forward P/E |
128.0x
|
33.2x
|
| EV / EBITDA |
31.0x
|
30.0x
|
| Price / Sales |
7.3x
|
5.8x
|
| Price / FCF |
22.1x
|
38.6x
|
| Revenue Growth YoY |
+12.4%
|
+21.0%
|
| Gross Margin |
70.7%
|
35.9%
|
| Operating Margin |
27.6%
|
17.7%
|
| Return on Equity |
68.0%
|
18.9%
|
| Dividend Yield |
0% |
0.98% |
| FCF Yield |
4.52%
|
2.59%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology and aesthetics. The company is transitioning from its historical Humira dominance, which has faced loss of exclusivity, toward high-growth assets like Skyrizi and Rinvoq that are driving robust revenue growth of 12.4% in the most recent quarter. Despite strong revenue growth and a dura…
Eaton is a 115-year-old power management company whose Electrical Americas, Electrical Global and Aerospace segments have become a core beneficiary of the same AI data-center, grid modernization and reshoring supercycle driving GE Vernova and Vertiv. Q2 2026 results were record-setting: revenue of $8.5 billion (up 21% year over year, 14% organic), adjusted EPS of $3.15, and segment margins of 23.…
Accumulation Zones
| Metric |
ABBV |
ETN |
| Zone Low |
$198.23 |
$305.00 |
| Zone High |
$224.66 |
$345.00 |
| In Buy Zone? |
No
|
No
|